Related Experiment Video
Updated: Apr 4, 2026
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.8K
Investigating molecular mechanisms for rhamnetin in oxidative damaged cardiomyocytes by microarray data analysis
Xudong Li1, Junli Gong, Hao Meng
1Department of Geriatric, the First Hospital of Ji Lin University, Changchun, China - kongjian-2005@163.com.
Minerva Cardioangiologica
|September 4, 2015
Summary
Rhamnetin shows potential for treating myocardial oxidative stress injury by modulating gene expression. This study identifies key molecular pathways and targets for developing new therapies for heart disease.
Area of Science:
- Molecular Biology
- Bioinformatics
- Cardiovascular Research
Background:
- Myocardial oxidative stress injury is a significant health concern.
- Rhamnetin's molecular mechanisms in cardiac cells require investigation.
- Identifying novel treatment targets for myocardial oxidative stress is crucial.
Purpose of the Study:
- To investigate the molecular mechanisms of rhamnetin in oxidative damaged myocardial cells.
- To identify potential therapeutic targets for myocardial oxidative stress injury using bioinformatic analysis.
Main Methods:
- RNA sequencing of H9c2 cells exposed to rhamnetin versus control.
- Differential gene expression analysis using NOISeq.
- Pathway and functional enrichment analysis (KEGG, GO BP) via DAVID.
- Protein-protein interaction network construction (STRING) and module analysis (MCODE).
Main Results:
- Identified 703 up-regulated and 749 down-regulated genes.
- Up-regulated genes enriched in Adherens junction, Notch signaling, and Focal adhesion pathways.
- Down-regulated genes enriched in oxidative phosphorylation, cell cycle, and metabolism pathways.
- Constructed a protein-protein interaction network with 609 nodes and identified key modules.
Conclusions:
- This study provides a theoretical basis for understanding rhamnetin's molecular mechanism.
- Identified potential therapeutic targets for myocardial diseases related to oxidative stress.
